We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,868 results
  1. Edaravone Maintains AQP4 Polarity Via OS/MMP9/β-DG Pathway in an Experimental Intracerebral Hemorrhage Mouse Model

    Oxidative stress (OS) is the main cause of secondary damage following intracerebral hemorrhage (ICH). The polarity expression of aquaporin-4 (AQP4)...

    Zhenhua Wang, Yuan Li, ... Weitian Lu in Molecular Neurobiology
    Article 29 February 2024
  2. miR-211-5p targeting MMP9 regulates the expressions of AQP4 in traumatic brain injury

    Objective

    The abnormal expression of matrix metalloproteinase 9 (MMP9) and Aquaporin 4 (AQP4) closely associates with the traumatic brain injury (TBI)...

    Meng Wang, **n Yu, ... Zhenzeng Fan in Acta Neurologica Belgica
    Article 05 April 2023
  3. Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action

    Hepatocellular carcinoma (HCC) is a serious and potentially fatal form of cancer associated with liver damage. New anticancer drugs are increasingly...

    Alaa Elmetwalli, Thoria Diab, ... Afrah Fatthi Salama in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 05 May 2023
  4. Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway

    Cysteine protease inhibitor S (CST4) plays a pivotal role in the regulation of growth, invasion, and metastasis of a variety of malignancies....

    Jiayi Guo, Zhengyu Song, ... Edris Awut in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 February 2024
  5. Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis

    Background

    Hepatocellular carcinoma (HCC) cell-derived exosomal LncRNA SNHG16 is highly expressed and associated with poor overall survival of...

    Ying Xu, Guangchao Luan, ... Yifu Chu in Cellular Oncology
    Article 25 November 2022
  6. Hydrogen attenuates postoperative pain through Trx1/ASK1/MMP9 signaling pathway

    Background

    Postoperative pain is a serious clinical problem with a poorly understood mechanism, and lacks effective treatment. Hydrogen (H 2 ) can...

    Juan Li, Shirong Ruan, ... Liang Hu in Journal of Neuroinflammation
    Article Open access 03 February 2023
  7. Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured in spheroids

    Background

    Cancer-associated fibroblasts (CAFs) are the major cellular component of the tumor microenvironment and are known to affect tumor growth...

    Max Rademaekers, Emil Oliver Johansson, ... Emilia Wiechec in Cancer Cell International
    Article Open access 31 May 2024
  8. Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

    We previously identified matrix metalloproteinase 2 (MMP2) and MMP9 plasma levels as candidate biomarkers of bevacizumab activity in patients with...

    Carine Jiguet-Jiglaire, Sebastien Boissonneau, ... Emeline Tabouret in Acta Neuropathologica Communications
    Article Open access 03 January 2022
  9. Caspase-9 inhibition decreases expression of Mmp9 during chondrogenesis

    Besides cell death, caspase-9 participates in non-apoptotic events, including cell differentiation. To evaluate a possible impact on the expression...

    A. Ramesova, B. Vesela, ... E. Matalova in Histochemistry and Cell Biology
    Article 09 January 2022
  10. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease

    Background

    Matrix metallopeptidase 9 (MMP9) has been implicated in a variety of neurological disorders, including Alzheimer’s disease (AD), where MMP9...

    Charis Ringland, Jonas Elias Schweig, ... Corbin Bachmeier in BMC Neuroscience
    Article Open access 25 May 2021
  11. Investigating the Effect of Silica Nanoparticles on MMP9, HAS2, ITGAX, and Additional Key Genes: Implications for Enhanced Wound Healing

    Abstract

    Nanoparticles are an essential aspect of current scientific evolution, offering several potential applications in a number of fields....

    B. Mando, A. Al Athamneh, ... A. Khaleel in Russian Journal of Genetics
    Article 01 February 2024
  12. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma

    Background

    Uveal melanoma (UVM) is the leading cause of eye-related mortality worldwide. This study aimed to explore the expression and prognostic...

    Tianyu Wang, Yuanyuan Zhang, ... Qing Peng in BMC Cancer
    Article Open access 29 September 2021
  13. Xanthohumol hinders invasion and cell cycle progression in cancer cells through targeting MMP2, MMP9, FAK and P53 genes in three-dimensional breast and lung cancer cells culture

    Background

    Despite recent advances in the treatment of lung and breast cancer, the mortality with these two types of cancer is high. Xanthohumol (XN)...

    Zohreh Gholizadeh Siahmazgi, Shiva Irani, ... Vahid Haghpanah in Cancer Cell International
    Article Open access 02 August 2023
  14. Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9

    Objectives

    This study aimed to identify novel targets in the carcinogenesis, therapy and prognosis of osteosarcoma from genomic level, together with...

    Weihang Li, Ziyi Ding, ... Ming Yan in Cancer Cell International
    Article Open access 14 July 2021
  15. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis

    Background

    Breast cancer (BC) is a leading cause of cancer-related death in females worldwide. Previous studies have demonstrated that matrix...

    Hanfang Jiang, Hui** Li in BMC Cancer
    Article Open access 10 February 2021
  16. TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9

    Breast cancer is the first killer leading to female death, and tumor metastasis is one of the important factors leading to the death of patients, but...

    Bowen Li, Liying Mu, ... Huijian Wu in Cancer Cell International
    Article Open access 11 January 2021
  17. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness

    Background

    Angiopoietin-like protein 1 (ANGPTL1) has been proved to suppress tumor metastasis in several cancers. However, its extracellular effects...

    Kai Jiang, Haiyan Chen, ... Kefeng Ding in Journal of Experimental & Clinical Cancer Research
    Article Open access 07 January 2021
  18. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation

    Purpose

    Targeting tumor-infiltrating macrophages limits progression and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma...

    Cansu Tekin, Hella L Aberson, ... C Arnold Spek in Cellular Oncology
    Article Open access 18 August 2020
  19. MiR-128-3p inhibits vascular smooth muscle cell proliferation and migration by repressing FOXO4/MMP9 signaling pathway

    Background

    MicroRNAs (miRNAs) have been identified as important participants in the development of atherosclerosis (AS). The present study explored...

    Chuan Qu, **n Liu, ... Bo Yang in Molecular Medicine
    Article Open access 25 November 2020
Did you find what you were looking for? Share feedback.